Raymond James & Associates’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-800
| Closed | -$2K | – | 3665 |
|
|
2019
Q1 | $2K | Hold |
800
| – | – | ﹤0.01% | 3481 |
|
|
2018
Q4 | $2K | Hold |
800
| – | – | ﹤0.01% | 3422 |
|
|
2018
Q3 | $4K | Hold |
800
| – | – | ﹤0.01% | 3493 |
|
|
2018
Q2 | $4K | Hold |
800
| – | – | ﹤0.01% | 3455 |
|
|
2018
Q1 | $6K | Hold |
800
| – | – | ﹤0.01% | 3342 |
|
|
2017
Q4 | $6K | Hold |
800
| – | – | ﹤0.01% | 3279 |
|
|
2017
Q3 | $7K | Hold |
800
| – | – | ﹤0.01% | 3252 |
|
|
2017
Q2 | $8K | Hold |
800
| – | – | ﹤0.01% | 3171 |
|
|
2017
Q1 | $9K | Hold |
800
| – | – | ﹤0.01% | 3120 |
|
|
2016
Q4 | $10K | Sell |
800
-50
| -6% | -$625 | ﹤0.01% | 3074 |
|
|
2016
Q3 | $16K | Hold |
850
| – | – | ﹤0.01% | 3048 |
|
|
2016
Q2 | $9K | Hold |
850
| – | – | ﹤0.01% | 2884 |
|
|
2016
Q1 | $16K | Buy |
+850
| New | +$16K | ﹤0.01% | 2799 |
|